Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety

To the Editor According to the study protocol, the recently published study by Aaronson et al1 was carried out “to assess effectiveness of 25 mg of psilocybin in [15] patients with treatment-resistant type 2 bipolar depression.” We see 3 concerns.

Open source BibTeX RIS

Bibliographic context

Journal
JAMA Psychiatry
Date
2024-04-09
Source
OpenAlex
DOI
10.1001/jamapsychiatry.2024.0420
PubMed
38598200

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Related papers